These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Purification and conjugation of type 1 ribosome-inactivating proteins. Barbieri L; Bolognesi A; Stirpe F Methods Mol Biol; 2001; 166():71-85. PubMed ID: 11217377 [No Abstract] [Full Text] [Related]
27. Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin. Stirpe F; Wawrzynczak EJ; Brown AN; Knyba RE; Watson GJ; Barbieri L; Thorpe PE Br J Cancer; 1988 Nov; 58(5):558-61. PubMed ID: 3265330 [TBL] [Abstract][Full Text] [Related]
28. A new 'solid phase' procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). Dosio F; Brusa P; Delprino L; Ceruti M; Grosa G; Cattel L; Bolognesi A; Barbieri L Farmaco; 1993 Jan; 48(1):105-15. PubMed ID: 8457275 [TBL] [Abstract][Full Text] [Related]
29. Molecular action of the type 1 ribosome-inactivating protein saporin 5 on Vicia sativa ribosomes. Iglesias R; Arias FJ; Rojo MA; Escarmis C; Ferreras JM; Girbés T FEBS Lett; 1993 Jul; 325(3):291-4. PubMed ID: 8319810 [TBL] [Abstract][Full Text] [Related]
30. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056 [TBL] [Abstract][Full Text] [Related]
31. Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane. Carroll SF; Bernhard SL; Goff DA; Bauer RJ; Leach W; Kung AH Bioconjug Chem; 1994; 5(3):248-56. PubMed ID: 7918744 [TBL] [Abstract][Full Text] [Related]
32. Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds of Trichosanthes anguina. Chow LP; Chou MH; Ho CY; Chuang CC; Pan FM; Wu SH; Lin JY Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):211-9. PubMed ID: 9931318 [TBL] [Abstract][Full Text] [Related]
33. An antimelanoma-barley ribosome inactivating protein conjugate is cytotoxic to melanoma cells in vitro. Ovadia M; Hager CC; Oeltmann TN Anticancer Res; 1990; 10(3):671-5. PubMed ID: 2369082 [TBL] [Abstract][Full Text] [Related]
35. High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers. Ohri R; Bhakta S; Fourie-O'Donohue A; Dela Cruz-Chuh J; Tsai SP; Cook R; Wei B; Ng C; Wong AW; Bos AB; Farahi F; Bhakta J; Pillow TH; Raab H; Vandlen R; Polakis P; Liu Y; Erickson H; Junutula JR; Kozak KR Bioconjug Chem; 2018 Feb; 29(2):473-485. PubMed ID: 29425028 [TBL] [Abstract][Full Text] [Related]
36. Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Ferreras JM; Barbieri L; Girbés T; Battelli MG; Rojo MA; Arias FJ; Rocher MA; Soriano F; Mendéz E; Stirpe F Biochim Biophys Acta; 1993 Oct; 1216(1):31-42. PubMed ID: 8218413 [TBL] [Abstract][Full Text] [Related]
37. Microenvironment of cysteine 242 in type-1 ribosome-inactivating protein from iris. Hao Q; Van Damme EJ; Barre A; Sillen A; Rougé P; Engelborghs Y; Peumans WJ Biochem Biophys Res Commun; 2000 Aug; 275(2):481-7. PubMed ID: 10964691 [TBL] [Abstract][Full Text] [Related]
38. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related]
39. Characterization of a saporin isoform with lower ribosome-inhibiting activity. Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741 [TBL] [Abstract][Full Text] [Related]